KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
002728 Teyi Pharmaceutical Group
- 9.63
- +0.09+0.94%
Market Closed Dec 13 15:00 CST
4.92BMarket Cap69.78P/E (TTM)
9.95High9.39Low428.41KlotVolume9.41Open9.54Pre Close416.43MTurnover11.44%Turnover Ratio19.42P/E (Static)510.79MShares13.3652wk High2.82P/B3.61BFloat Cap6.7952wk Low10.49Limit Up374.66MShs Float20.62Historical High8.59Limit Down5.87%Amplitude2.21Historical Low0.36Dividend TTM9.72Avg Price203.80KlotAsk3.71%Div YieldTTM100Lot Size210.38KlotBid
Teyi Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -38.87%455.6M | -41.72%313.75M | -45.88%164.61M | 20.38%1.07B | 27.83%745.29M | 39.79%538.38M | 56.50%304.16M | 16.94%886.57M | 10.96%583.05M | 7.51%385.14M |
| Operating revenue | -38.87%455.6M | -41.72%313.75M | -45.88%164.61M | 20.38%1.07B | 27.83%745.29M | 39.79%538.38M | 56.50%304.16M | 16.94%886.57M | 10.96%583.05M | 7.51%385.14M |
| Other operating revenue | ---- | 18.25%472.19K | ---- | 74.15%741.44K | ---- | 96.55%399.33K | ---- | 84.10%425.74K | ---- | 41.75%203.17K |
| Total operating cost | -13.02%461.05M | -12.17%318.75M | -13.39%156.73M | 10.23%768.83M | 10.40%530.07M | 14.41%362.94M | 29.16%180.96M | 15.65%697.48M | 13.59%480.12M | 11.50%317.22M |
| Operating cost | -11.62%278.66M | -14.59%189.65M | -18.88%91.71M | 3.58%467.99M | 2.74%315.31M | 8.61%222.05M | 22.03%113.06M | 26.89%451.83M | 23.87%306.91M | 25.87%204.45M |
| Operating tax surcharges | -36.92%4.91M | -41.25%3.31M | -52.42%1.56M | 24.46%12.28M | 26.44%7.78M | 35.39%5.63M | 43.37%3.28M | 6.40%9.87M | 0.41%6.15M | 6.71%4.16M |
| Operating expense | -22.25%94.63M | -12.84%70.26M | 1.51%36.07M | 48.52%174.36M | 57.60%121.72M | 73.50%80.62M | 114.98%35.53M | -1.13%117.4M | -1.63%77.23M | -17.39%46.47M |
| Administration expense | 6.61%50.29M | 12.19%34.42M | 7.56%17.6M | 12.43%66.31M | 13.01%47.18M | 10.91%30.68M | 20.62%16.36M | 3.09%58.99M | -0.78%41.74M | -0.44%27.66M |
| Financial expense | -122.69%-1.27M | -113.39%-546.77K | -151.80%-1.32M | -77.44%4.82M | -72.13%5.62M | -75.25%4.08M | -60.49%2.54M | -10.90%21.39M | -6.79%20.16M | 2.09%16.5M |
| -Interest expense (Financial expense) | -71.46%4M | -64.73%3.37M | -65.48%1.39M | -43.83%16.36M | -43.14%14.03M | -48.34%9.55M | -43.17%4.02M | -1.29%29.13M | -1.94%24.68M | -2.06%18.49M |
| -Interest Income (Financial expense) | 33.70%-5.79M | 25.40%-4.25M | -86.09%-2.81M | -45.87%-11.98M | -75.63%-8.74M | -139.55%-5.7M | -111.40%-1.51M | -40.84%-8.21M | -28.71%-4.97M | 20.67%-2.38M |
| Research and development | 4.19%33.83M | 8.95%21.66M | 9.02%11.1M | 13.30%43.06M | 16.29%32.47M | 10.48%19.88M | 17.71%10.18M | 0.62%38.01M | 5.12%27.92M | 0.08%17.99M |
| Credit Impairment Loss | 17.84%1.72M | 10.75%1.9M | -45.22%1.53M | 97.62%-35.01K | 869.74%1.46M | 338.68%1.71M | 925.10%2.8M | 18.94%-1.47M | 83.34%-189.8K | -699.46%-718.26K |
| Asset Impairment Loss | ---- | ---- | ---- | ---13.16M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | 79.10%8.29M | 76.75%6.55M | -10.79%3.43M | -168.51%-5.11M | -41.39%4.63M | -31.88%3.71M | 1,186.71%3.85M | 151.41%7.46M | -9.60%7.9M | -41.66%5.44M |
| Invest income | 602.52%1.9M | --1.05M | --21.47K | 6.29%360.81K | -20.44%270.08K | ---- | ---- | -94.62%339.46K | -94.62%339.46K | -95.84%262.39K |
| Asset deal income | -93.59%7.73K | -99.83%204.42 | ---- | 199.24%122.08K | 195.67%120.63K | 392.29%120.36K | ---- | -57.20%40.8K | --40.8K | --24.45K |
| Other revenue | 67.93%4.67M | 92.63%3.61M | 79.22%1.88M | -11.02%7.6M | -63.96%2.78M | -68.11%1.87M | 64.04%1.05M | 113.62%8.55M | 115.89%7.71M | 102.40%5.87M |
| Operating profit | -98.71%2.84M | -99.13%1.55M | -91.10%11.31M | 49.21%293.27M | 98.37%219.85M | 144.22%179.15M | 132.95%127.04M | 39.82%196.55M | -0.63%110.83M | -11.69%73.36M |
| Add:Non operating Income | -2.68%7.14K | -75.56%1.72K | -98.07%120.29 | 44.07%106.8K | -89.63%7.33K | -90.01%7.04K | -68.82%6.24K | -99.03%74.13K | -99.04%70.74K | -98.95%70.45K |
| Less:Non operating expense | 312.35%653.67K | 482.51%457.4K | 363.02%119.13K | 29.20%384.25K | -11.01%158.52K | -55.92%78.52K | -85.14%25.73K | -72.35%297.4K | -75.36%178.14K | -35.00%178.14K |
| Total profit | -99.00%2.19M | -99.39%1.1M | -91.19%11.19M | 49.24%292.99M | 98.42%219.7M | 144.48%179.08M | 133.57%127.02M | 33.46%196.32M | -6.33%110.72M | -18.19%73.25M |
| Less:Income tax cost | -112.22%-3.82M | -105.91%-1.59M | -90.54%2.04M | 119.74%39.82M | 140.91%31.22M | 128.67%26.96M | 147.22%21.55M | -10.21%18.12M | -15.54%12.96M | -17.10%11.79M |
| Net profit | -96.81%6.01M | -98.23%2.69M | -91.32%9.15M | 42.07%253.18M | 92.79%188.48M | 147.51%152.13M | 130.96%105.47M | 40.41%178.2M | -4.96%97.77M | -18.39%61.46M |
| Net profit from continuing operation | -96.81%6.01M | -98.23%2.69M | -91.32%9.15M | 42.07%253.18M | 92.79%188.48M | 147.51%152.13M | 130.96%105.47M | 40.41%178.2M | -4.96%97.77M | -18.39%61.46M |
| Net profit of parent company owners | -96.81%6.01M | -98.23%2.69M | -91.32%9.15M | 42.07%253.18M | 92.79%188.48M | 147.51%152.13M | 130.96%105.47M | 40.41%178.2M | -4.96%97.77M | -18.39%61.46M |
| Earning per share | ||||||||||
| Basic earning per share | -97.62%0.01 | -98.53%0.005 | -90.91%0.03 | 35.09%0.77 | 31.25%0.42 | 70.00%0.34 | 57.14%0.33 | -8.06%0.57 | -37.25%0.32 | -45.95%0.2 |
| Diluted earning per share | -97.56%0.01 | -98.48%0.005 | -90.63%0.03 | 35.09%0.77 | 28.13%0.41 | 65.00%0.33 | 60.00%0.32 | -8.06%0.57 | -37.25%0.32 | -45.95%0.2 |
| Other composite income | ||||||||||
| Total composite income | -96.81%6.01M | -98.23%2.69M | -91.32%9.15M | 42.07%253.18M | 92.79%188.48M | 147.51%152.13M | 130.96%105.47M | 40.41%178.2M | -4.96%97.77M | -18.39%61.46M |
| Total composite income of parent company owners | -96.81%6.01M | -98.23%2.69M | -91.32%9.15M | 42.07%253.18M | 92.79%188.48M | 147.51%152.13M | 130.96%105.47M | 40.41%178.2M | -4.96%97.77M | -18.39%61.46M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
